Lorazepam is contraindicated in patients with an anaphylactic reaction to lorazepam, any component of the formulation, or other benzodiazepines (cross-sensitivity with other benzodiazepines may exist).

It is contraindicated to use in neonates or premature infants, in patients with severe respiratory impairment (except during mechanical ventilation), acute narrow-angle glaucoma, sleep apnea, severe respiratory insufficiency, and intra-arterial administration route.

Lorazepam and other benzodiazepines should not be first-line agents for anxiety and other psychiatric disorder symptoms in the first and third trimesters of pregnancy.

Lorazepam and other benzodiazepines have an increased risk of abuse, misuse, and dependence; these medications are contraindicated in patients actively using illicit substances and drugs. Except for use in Alcohol withdrawal disorder symptoms and detoxification, lorazepam and other benzodiazepine are contraindicated in patients withÂ a history of alcohol dependence and abuse and not in remission. Increased risk of fatality with the combined use of alcohol and lorazepam in overdose, including death.

Injection formulation contains polyethylene glycol, propylene glycol, or benzyl alcohol, so contraindications include hypersensitivity to these excipients.

**Box Warning:**Concomitant use of benzodiazepines with opioids can lead to sedation, severe respiratory depression, coma, and death. Avoid this combination.